Medical Center Verum
Kyiv 3039
0 studies enrolling now · 3 studies all time
What they study most
Breast Cancer, Endometrial Cancer, Triple Negative Breast Cancer
Studies at this site
- Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC — Running, not enrolling
- SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma — Completed
- Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer — Completed